Table of Contents Author Guidelines Submit a Manuscript
International Journal of Alzheimer’s Disease
Volume 2012, Article ID 731526, 13 pages
http://dx.doi.org/10.1155/2012/731526
Review Article

Structure and Pathology of Tau Protein in Alzheimer Disease

1Laboratory of Biochemistry and Brain Pathophysiology and AD Center, Prague Psychiatric Center, Ústavní 91, 181 03 Prague 8, Czech Republic
2Third Faculty of Medicine, Charles University in Prague, Ruská 87, 100 00 Prague 10, Czech Republic
3Department of Cell Biology, Center of Research and Advanced Studies, National Polytechnic Institute, Avenue Instituto Politecnico Nacional 2508, 07360 Mexico City, DF, Mexico
4Department of Neurology, Third Faculty of Medicine, Faculty Hospital Královské Vinohrady, Charles University in Prague, Šrobárova 50, 100 34 Prague 10, Czech Republic

Received 19 January 2012; Revised 28 March 2012; Accepted 29 March 2012

Academic Editor: David Blum

Copyright © 2012 Michala Kolarova et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [145 citations]

The following is the list of published articles that have cited the current article.

  • Komal Saxena, Zeeshan, Mridul Kumar, K. S. Daya, and Anirban Bandyopadhyay, “Detection of Milimeter Wave Properties of Beta Amyloid using Dielectric Filled Truncated Cylindrical Waveguide,” 2019 URSI Asia-Pacific Radio Science Conference (AP-RASC), pp. 1–4, . View at Publisher · View at Google Scholar
  • Ales Bartos, Lenka Fialova, Jana Svarcova, and Daniela Ripova, “Patients with Alzheimer disease have elevated intrathecal synthesis of antibodies against tau protein and heavy neurofilament,” Journal Of Neuroimmunology, vol. 252, no. 1-2, pp. 100–105, 2012. View at Publisher · View at Google Scholar
  • Sunmin Park, Da Sol Kim, Suna Kang, and Na Rang Moon, “β-Amyloid-induced cognitive dysfunction impairs glucose homeostasis by increasing insulin resistance and decreasing β-cell mass in non-diabetic and diabetic rats,” Metabolism, 2013. View at Publisher · View at Google Scholar
  • Jan Říčný, “Overlooked Alzheimer’s Smoking Gun?,” Neurochemical Research, 2013. View at Publisher · View at Google Scholar
  • Ramasamy Thangavel, Duraisamy Kempuraj, Deirdre Stolmeier, Poojya Anantharam, Mohammad Khan, and Asgar Zaheer, “Glia Maturation Factor Expression in Entorhinal Cortex of Alzheimer’s Disease Brain,” Neurochemical Research, 2013. View at Publisher · View at Google Scholar
  • Yancy Ferrer-Acosta, Eva N. Rodríguez-Cruz, François Orange, Hector De Jesús-Cortés, Bismark Madera, Jaime Vaquer-Alicea, Juan Ballester, Maxime J.-F. Guinel, George S. Bloom, and Irving E. Vega, “EFhd2 is a novel amyloid protein associated with pathological tau in Alzheimer's disease,” Journal of Neurochemistry, vol. 125, no. 6, pp. 921–931, 2013. View at Publisher · View at Google Scholar
  • Wolfgang Froestl, Andrea Pfeifer, and Andreas Muhs, “Cognitive Enhancers (Nootropics). Part 3: Drugs Interacting with Targets other than Receptors or Enzymes. Disease-modifying Drugs,” Journal Of Alzheimers Disease, vol. 34, no. 1, pp. 1–114, 2013. View at Publisher · View at Google Scholar
  • Khushwant S. Bhullar, and H. P. Vasantha Rupasinghe, “Polyphenols: Multipotent Therapeutic Agents in Neurodegenerative Diseases,” Oxidative Medicine and Cellular Longevity, vol. 2013, pp. 1–18, 2013. View at Publisher · View at Google Scholar
  • Anna Minarini, Andrea Milelli, Michela Rosini, Maria Laura Bolognesi, Chiara Marchetti, Elena Simoni, and Vincenzo Tumiatti, “Multifunctional tacrine derivatives in Alzheimer's disease,” Current Topics in Medicinal Chemistry, vol. 13, no. 15, pp. 1771–1786, 2013. View at Publisher · View at Google Scholar
  • Bruno Bulic, Marcus Pickhardt, and Eckhard Mandelkow, “Progress and Developments in Tau Aggregation Inhibitors for Alzheimer Disease,” Journal Of Medicinal Chemistry, vol. 56, no. 11, pp. 4135–4155, 2013. View at Publisher · View at Google Scholar
  • Shraddha D. Rege, Thangiah Geetha, Gerald D. Griffin, Tom L. Broderick, and Jeganathan Ramesh Babu, “Neuroprotective effects of resveratrol in Alzheimer disease pathology,” Frontiers in Aging Neuroscience, vol. 6, 2014. View at Publisher · View at Google Scholar
  • P. Cermakova, M. Eriksdotter, L. H. Lund, B. Winblad, P. Religa, and D. Religa, “Heart failure and Alzheimer′s disease,” Journal of Internal Medicine, 2014. View at Publisher · View at Google Scholar
  • Julia E. Gerson, Diana L. Castillo-Carranza, and Rakez Kayed, “Advances in Therapeutics for Neurodegenerative Tauopathies: Moving toward the Specific Targeting of the Most Toxic Tau Species,” ACS Chemical Neuroscience, pp. 140808101712009, 2014. View at Publisher · View at Google Scholar
  • Tamás Vajda, and András Perczel, “Role of water in protein folding, oligomerization, amyloidosis and miniprotein,” Journal of Peptide Science, 2014. View at Publisher · View at Google Scholar
  • Fouad H. Darras, Sarah Wehle, Guozheng Huang, Christoph A. Sotriffer, and Michael Decker, “Amine substitution of quinazolinones leads to selective nanomolar AChE inhibitors with “inverted” binding mode,” Bioorganic & Medicinal Chemistry, 2014. View at Publisher · View at Google Scholar
  • Dante J. Marciani, “New Th2 adjuvants for preventive and active immunotherapy of neurodegenerative proteinopathies,” Drug Discovery Today, vol. 19, no. 7, pp. 912–920, 2014. View at Publisher · View at Google Scholar
  • Min Xie, Shao-Hui Wang, Zhi-Min Lu, Ying Pan, and Qi-Cai Chen, “UCH-L1 Inhibition Involved in CREB Dephosphorylation in Hippocampal Slices,” Journal of Molecular Neuroscience, vol. 53, no. 1, pp. 59–68, 2014. View at Publisher · View at Google Scholar
  • Nasimudeen R. Jabir, Chelaprom K. Firoz, Aabgeena Naeem, Ibrahim M. Alhazza, Mohammad A. Kamal, Iftekhar Hassan, Shams Tabrez, Syed K. Zaidi, Ghulam M. Ashraf, Ghazi A. Damanhouri, Nigel H. Greig, Taqi A. Khan, Shazi Shakil, Ishfaq A. Sheikh, and Mohammad Akram, “Protein misfolding and aggregation in Alzheimer’s disease and type 2 diabetes mellitus,” CNS and Neurological Disorders - Drug Targets, vol. 13, no. 7, pp. 1280–1293, 2014. View at Publisher · View at Google Scholar
  • Fehmida Bibi, Esam I. Azhar, Muhammad Yasir, Sayed S. Sohrab, Mohammed H. Al-Qahtani, Adel M. Abuzenadah, Mohammad A. Kamal, and Muhammad I. Naseer, “Link between chronic bacterial inflammation and Alzheimer disease,” CNS and Neurological Disorders - Drug Targets, vol. 13, no. 7, pp. 1140–1147, 2014. View at Publisher · View at Google Scholar
  • Chiara Appocher, Raffaella Klima, and Fabian Feiguin, “Functional screening in Drosophila reveals the conserved role of REEP1 in promoting stress resistance and preventing the formation of Tau aggregates,” Human Molecular Genetics, vol. 23, no. 25, pp. 6762–6772, 2014. View at Publisher · View at Google Scholar
  • Sandra Reeg, and Tilman Grune, “Protein Oxidation in Aging: Does It Play a Role in Aging Progression?,” Antioxidants & Redox Signaling, pp. 141009073447009, 2014. View at Publisher · View at Google Scholar
  • Sungsu Lim, Md. Mamunul Haque, Dohee Kim, Dong Jin Kim, and Yun Kyung Kim, “Cell-based models to investigate tau aggregation,” Computational and Structural Biotechnology Journal, 2014. View at Publisher · View at Google Scholar
  • Xin Zhou, Chun Yang, Yufeng Liu, Peng Li, Huiying Yang, Jingxing Dai, Rongmei Qu, and Lin Yuan, “Lipid rafts participate in aberrant degradative autophagic-lysosomal pathway of amyloid-beta peptide in Alzheimer's disease,” Neural Regeneration Research, vol. 9, no. 1, pp. 92–100, 2014. View at Publisher · View at Google Scholar
  • Bernardo A. Petriz, and Octavio Luiz Franco, “Application of Cutting-Edge Proteomics Technologies for Elucidating Host–Bacteria Interactions,” Proteomics in Biomedicine and Pharmacology, vol. 95, pp. 1–24, 2014. View at Publisher · View at Google Scholar
  • Kina Hoglund, Anthony Fourier, Armand Perret-Liaudet, Henrik Zetterberg, Kaj Blennow, and Erik Portelius, “Alzheimer's disease - Recent biomarker developments in relation to updated diagnostic criteria,” Clinica Chimica Acta, vol. 449, pp. 3–8, 2015. View at Publisher · View at Google Scholar
  • Min Xie, Yun Han, Quntao Yu, Xia Wang, Shaohui Wang, and Xiaomei Liao, “UCH-L1 Inhibition Decreases the Microtubule-Binding Function of Tau Protein,” Journal of Alzheimer's Disease, vol. 49, no. 2, pp. 353–363, 2015. View at Publisher · View at Google Scholar
  • Anu Rani, Neha, Rupinder K. Sodhi, and Amanpreet Kaur, “Protective effect of a calcium channel blocker “diltiazem” on aluminum chloride-induced dementia in mice,” Naunyn-Schmiedeberg's Archives of Pharmacology, 2015. View at Publisher · View at Google Scholar
  • David A. Loeffler, Lynnae M. Smith, Andrea C. Klaver, and Sanela Martić, “Effects of antibodies to phosphorylated and non-phosphorylated tau on in vitro tau phosphorylation at Serine-199: Preliminary report,” Experimental Gerontology, vol. 67, pp. 15–18, 2015. View at Publisher · View at Google Scholar
  • Jan Torleif Pedersen, and Einar M. Sigurdsson, “Tau immunotherapy for Alzheimer's disease,” Trends In Molecular Medicine, vol. 21, no. 6, pp. 394–402, 2015. View at Publisher · View at Google Scholar
  • Oliver Reimann, Maria Glanz, and Christian P. R. Hackenberger, “Native chemical ligation between asparagine and valine: Application and limitations for the synthesis of tri-phosphorylated C-terminal tau,” Bioorganic & Medicinal Chemistry, vol. 23, no. 12, pp. 2890–2894, 2015. View at Publisher · View at Google Scholar
  • Shraddha D. Rege, Thangiah Geetha, Tom L. Broderick, and Jeganathan Ramesh Babu, “Resveratrol protects β amyloid-induced oxidative damage and memory associated proteins in H19-7 hippocampal neuronal cells,” Current Alzheimer Research, vol. 12, no. 2, pp. 147–156, 2015. View at Publisher · View at Google Scholar
  • Dong-Young Choi, and Hyukjae Choi, “Natural products from marine organisms with neuroprotective activity in the experimental models of Alzheimer's disease, Parkinson's disease and ischem,” Archives Of Pharmacal Research, vol. 38, no. 2, pp. 139–170, 2015. View at Publisher · View at Google Scholar
  • Lenka Hromadkova, Michala Kolarova, Barbora Jankovicova, Ales Bartos, Jan Ricny, Zuzana Bilkova, and Daniela Ripova, “Identification and characterization of natural antibodies against tau protein in an intravenous immunoglobulin product,” Journal Of Neuroimmunology, vol. 289, pp. 121–129, 2015. View at Publisher · View at Google Scholar
  • O. G. Tatarnikova, M. A. Orlov, and N. V. Bobkova, “Beta-Amyloid and Tau-Protein: Structure, Interaction, and Prion-Like Properties,” Biochemistry-Moscow, vol. 80, no. 13, pp. 1800–1819, 2015. View at Publisher · View at Google Scholar
  • Emilio Badoer, Samin Kosari, and Martin J. Stebbing, “Resistin, an Adipokine with Non-Generalized Actions on Sympathetic Nerve Activity,” Frontiers in Physiology, vol. 6, 2015. View at Publisher · View at Google Scholar
  • Dohee Kim, Sungsu Lim, Md. Mamunul Haque, Nayeon Ryoo, Hyun Seok Hong, Hyewhon Rhim, Dong-Eun Lee, Young-Tae Chang, Jun-Seok Lee, Eunji Cheong, Dong Jin Kim, and Yun Kyung Kim, “Identification of disulfide cross-linked tau dimer responsible for tau propagation,” Scientific Reports, vol. 5, pp. 15231, 2015. View at Publisher · View at Google Scholar
  • Yu Jin, Takeshi Kanno, and Tomoyuki Nishizaki, “Acute Restraint Stress Impairs Induction of Long-Term Potentiation by Activating GSK-3 beta,” Neurochemical Research, vol. 40, no. 1, pp. 36–40, 2015. View at Publisher · View at Google Scholar
  • Iftikhar Aslam Tayubi, Ahmad Firoz, and Adeel Malikpp. 119–135, 2015. View at Publisher · View at Google Scholar
  • Heiko Braak, Kelly Del Tredici, Heiko Braak, and Kelly Del Tredici, “Neuroanatomy and Pathology of Sporadic Alzheimer’s Disease,” Advances in Anatomy Embryology and Cell Biology, vol. 215, 2015. View at Publisher · View at Google Scholar
  • Andrea Spolcova, Barbora Mikulaskova, Martina Holubova, Veronika Nagelova, Zdenko Pirnik, Jana Zemenova, Martin Haluzik, Blanka Zelezna, Marie-Christine Galas, and Lenka Maletinska, “Anorexigenic Lipopeptides Ameliorate Central Insulin Signaling and Attenuate Tau Phosphorylation in Hippocampi of Mice with Monosodium Glutamate-Induc,” Journal Of Alzheimers Disease, vol. 45, no. 3, pp. 823–835, 2015. View at Publisher · View at Google Scholar
  • Karinne Marieta Carvalho, Eduardo Winter, and Adelaide Maria de Souza Antunes, “Analysis of Technological Developments in the Treatment of Alzheimer’s Disease through Patent Documents,” Intelligent Information Management, vol. 07, no. 05, pp. 268–281, 2015. View at Publisher · View at Google Scholar
  • Tomoyuki Esumi, Yoshiyasu Fukuyama, and Hiroshi Imagawa, “Synthetic studies of neurite outgrowth-promoting neovibsanins,” Yuki Gosei Kagaku Kyokaishi/Journal of Synthetic Organic Chemistry, vol. 73, no. 9, pp. 902–910, 2015. View at Publisher · View at Google Scholar
  • Zhenzhen Liu, Tao Li, Ping Li, Nannan Wei, Zhiquan Zhao, Huimin Liang, Xinying Ji, Wenwu Chen, Mengzhou Xue, and Jianshe Wei, “The Ambiguous Relationship of Oxidative Stress, Tau Hyperphosphorylation, and Autophagy Dysfunction in Alzheimer’s Disease,” Oxidative Medicine and Cellular Longevity, vol. 2015, pp. 1–12, 2015. View at Publisher · View at Google Scholar
  • Alexei A. Adzhubei, Anastasia A. Anashkina, and Alexander A. Makarov, “Left-handed polyproline-II helix revisited: proteins causing proteopathies,” Journal of Biomolecular Structure and Dynamics, pp. 1–13, 2016. View at Publisher · View at Google Scholar
  • Francesco Panza, Antonio Greco, Giancarlo Logroscino, Vincenzo Solfrizzi, Madia Lozupone, Antonio Daniele, Alberto Pilotto, Davide Seripa, Bruno P. Imbimbo, Andrea Santamato, Rosanna Tortelli, Ilaria Galizia, and Camilla Prete, “Tau-based therapeutics for Alzheimer's disease: Active and passive immunotherapy,” Immunotherapy, vol. 8, no. 9, pp. 1119–1134, 2016. View at Publisher · View at Google Scholar
  • Mohammad Haddadi, Samaneh Reiszadeh Jahromi, Upendra Nongthomba, T. Shivanandappa, and S.R. Ramesh, “4-Hydroxyisophthalic acid from Decalepis hamiltonii rescues the neurobehavioral deficit in transgenic Drosophila model of taupathies,” Neurochemistry International, 2016. View at Publisher · View at Google Scholar
  • Simona Scarano, Samuele Lisi, Corinne Ravelet, Eric Peyrin, and Maria Minunni, “Detecting Alzheimer's Disease biomarkers: from antibodies to new bio-mimetic receptors and their application to established and emerging bioanalytical platforms - A critical review,” Analytica Chimica Acta, 2016. View at Publisher · View at Google Scholar
  • Donald Sikazwe, Sushma Ramsinghani, Malik Khan, and Raghunandan Yendapally, “Alzheimer’s drug discovery maze: A snap view of the past decade’s diverse pharmacological targets for the disorder,” Mini-Reviews in Medicinal Chemistry, vol. 16, 2016. View at Publisher · View at Google Scholar
  • Mark T.W. Ebbert, Ronald G. Munger, Christopher D. Corcoran, Ariel A. Hippen, Maria C. Norton, JoAnn T. Tschanz, and John S.K. Kauwe, “Presenilin E318G variant and Alzheimer's disease risk: The Cache County study,” BMC Genomics, vol. 17, 2016. View at Publisher · View at Google Scholar
  • Ajeet Kaushik, Rahul Dev Jayant, Sneham Tiwari, Arti Vashist, and Madhavan Nair, “Nano-biosensors to detect beta-amyloid for Alzheimer's disease management,” Biosensors and Bioelectronics, vol. 80, pp. 273–287, 2016. View at Publisher · View at Google Scholar
  • Steffen Kutter, Timo Eichner, Alexandra M. Deaconescu, and Dorothee Kern, “Regulation of Microtubule Assembly by Tau and not by Pin1,” Journal Of Molecular Biology, vol. 428, no. 9, pp. 1742–1759, 2016. View at Publisher · View at Google Scholar
  • Jonathan Gilley, Kunie Ando, Anjan Seereeram, Teresa Rodriguez-Martin, Amy M. Pooler, Laura Sturdee, Brian H. Anderton, Jean-Pierre Brion, Diane P. Hanger, and Michael P. Coleman, “Mislocalization of neuronal tau in the absence of tangle pathology in phosphomutant tau knockin mice,” Neurobiology Of Aging, vol. 39, pp. 1–18, 2016. View at Publisher · View at Google Scholar
  • Davide Seripa, Vincenzo Solfrizzi, Bruno P. Imbimbo, Antonio Daniele, Andrea Santamato, Madia Lozupone, Giovanni Zuliani, Antonio Greco, Giancarlo Logroscino, and Francesco Panza, “Tau-directed approaches for the treatment of Alzheimer's disease: focus on leuco-methylthioninium,” Expert Review Of Neurotherapeutics, vol. 16, no. 3, pp. 259–277, 2016. View at Publisher · View at Google Scholar
  • Yanfang Li, Hao Sun, Zhicai Chen, Huaxi Xu, Guojun Bu, and Hui Zheng, “Implications of GABAergic Neurotransmission in Alzheimer’s Disease,” Frontiers in Aging Neuroscience, vol. 8, 2016. View at Publisher · View at Google Scholar
  • Liang Xu, Jie Zheng, Martin Margittai, Ruth Nussinov, and Buyong Ma, “How Does Hyperphopsphorylation Promote Tau Aggregation and Modulate Filament Structure and Stability?,” ACS Chemical Neuroscience, 2016. View at Publisher · View at Google Scholar
  • Da Hye Kim, Cheol-Ho Pan, Md Nazmul Huda, Erdenedolgor Erdene-Ochir, and Yoon Suk Kim, “Expression, phosphorylation, localization, and microtubule binding of tau in colorectal cell lines,” Applied Biological Chemistry, vol. 59, no. 6, pp. 807–812, 2016. View at Publisher · View at Google Scholar
  • Florent X. Smit, Jurriaan A. Luiken, and Peter G. Bolhuis, “ Primary Fibril Nucleation of Aggregation Prone Tau Fragments PHF6 and PHF6 * ,” The Journal of Physical Chemistry B, 2016. View at Publisher · View at Google Scholar
  • Tao Wang, Qiwen Wang, Ruilong Song, Yajing Zhang, Jinlong Yang, Yi Wang, Yan Yuan, Jianchun Bian, Xuezhong Liu, Jianhong Gu, Jiaqiao Zhu, and Zongping Liu, “Cadmium induced inhibition of autophagy is associated with microtubule disruption and mitochondrial dysfunction in primary rat cerebral cortical neuro,” Neurotoxicology And Teratology, vol. 53, pp. 11–18, 2016. View at Publisher · View at Google Scholar
  • Ramon Yarza, Silvia Vela, Maite Solas, and Maria J. Ramirez, “c-Jun N-terminal Kinase (JNK) Signaling as a Therapeutic Target for Alzheimer’s Disease,” Frontiers in Pharmacology, vol. 6, 2016. View at Publisher · View at Google Scholar
  • Jonathan J. Sabbagh, and Chad A. Dickey, “The Metamorphic Nature of the Tau Protein: Dynamic Flexibility Comes at a Cost,” Frontiers in Neuroscience, vol. 10, 2016. View at Publisher · View at Google Scholar
  • Moran Frenkel-Pinter, Sharon Tal, Roni Scherzer-Attali, Malak Abu-Hussien, Idan Alyagor, Tal Eisenbaum, Ehud Gazit, and Daniel Segal, “Naphthoquinone-Tryptophan Hybrid Inhibits Aggregation of the Tau-Derived Peptide PHF6 and Reduces Neurotoxicity,” Journal Of Alzheimers Disease, vol. 51, no. 1, pp. 165–178, 2016. View at Publisher · View at Google Scholar
  • Francesco Panza, Vincenzo Solfrizzi, Davide Seripa, Bruno P. Imbimbo, Madia Lozupone, Andrea Santamato, Chiara Zecca, Maria Rosaria Barulli, Antonello Bellomo, Alberto Pilotto, Antonio Daniele, Antonio Greco, and Giancarlo Logroscino, “Tau-Centric Targets and Drugs in Clinical Development for the Treatment of Alzheimer’s Disease,” BioMed Research International, vol. 2016, pp. 1–15, 2016. View at Publisher · View at Google Scholar
  • Lenka Fialova, Ales Bartos, and Jana Svarcova, “Neurofilaments and tau proteins in cerebrospinal fluid and serum in dementias and neuroinflammation,” Biomedical Papers, 2017. View at Publisher · View at Google Scholar
  • Tania Ismail, Mathumai Kanapathipillai, and Keerthi Nadimidla, “Tau peptides and tau mutant protein aggregation inhibition by cationic polyethyleneimine and polyarginine,” Biopolymers, vol. 107, no. 9, 2017. View at Publisher · View at Google Scholar
  • Ana M. Mata, “Functional interplay between Plasma Membrane Ca 2+ -ATPase, amyloid β-peptide and tau,” Neuroscience Letters, 2017. View at Publisher · View at Google Scholar
  • Sana Afreen, D. Nicole Riherd Methner, and Adriana Ferreira, “Tau 45-230 association with the cytoskeleton and membrane-bound organelles: Functional implications in neurodegeneration,” Neuroscience, 2017. View at Publisher · View at Google Scholar
  • Chu, Praticò, and Lauretti, “Caspase-3-dependent cleavage of Akt modulates tau phosphorylation via GSK3β kinase: Implications for Alzheimer's disease,” Molecular Psychiatry, vol. 22, no. 7, pp. 1002–1008, 2017. View at Publisher · View at Google Scholar
  • Ji-Sha Tian, Qi-Jin Zhai, Ying Zhao, Rui Chen, and Lian-Dong Zhao, “2-(2-benzofuranyl)-2-imidazoline (2-BFI) improved the impairments in AD rat models by inhibiting oxidative stress, inflammation and apoptosis,” Journal of Integrative Neuroscience, pp. 1–16, 2017. View at Publisher · View at Google Scholar
  • Olusiji Akinrinmade, Sandra Jordaan, Dmitrij Hristodorov, Radoslav Mladenov, Neelakshi Mungra, Shivan Chetty, and Stefan Barth, “Human MAP Tau Based Targeted Cytolytic Fusion Proteins,” Biomedicines, vol. 5, no. 3, pp. 36, 2017. View at Publisher · View at Google Scholar
  • Kitipong Promyo, Sun-Young Park, Jeong-Yong Cho, Kyung-Hee Park, Lily Jaiswal, and Kyung-Sik Ham, “Artemisia scoparia attenuates amyloid β accumulation and tau hyperphosphorylation in spontaneously hypertensive rats,” Food Science and Biotechnology, vol. 26, no. 3, pp. 775–782, 2017. View at Publisher · View at Google Scholar
  • María Berrocal, Isaac Corbacho, M. Rosario Sepulveda, Carlos Gutierrez-Merino, and Ana M. Mata, “Phospholipids and calmodulin modulate the inhibition of PMCA activity by tau,” Biochimica et Biophysica Acta - Molecular Cell Research, vol. 1864, no. 6, pp. 1028–1035, 2017. View at Publisher · View at Google Scholar
  • Rohit Pardeshi, Nityanand Bolshette, Kundlik Gadhave, Ashutosh Ahire, Sahabuddin Ahmed, Tommaso Cassano, Veer Bala Gupta, and Mangala Lahkar, “Insulin signaling: An opportunistic target to minify risk of Alzheimer’s disease,” Psychoneuroendocrinology, 2017. View at Publisher · View at Google Scholar
  • Moran Frenkel-Pinter, Shiri Stempler, Sharon Tal-Mazaki, Yelena Losev, Avnika Singh-Anand, Daniela Escobar-Álvarez, Jonathan Lezmy, Ehud Gazit, Eytan Ruppin, and Daniel Segal, “Altered protein glycosylation predicts Alzheimer's disease and modulates its pathology in disease model Drosophila,” Neurobiology of Aging, 2017. View at Publisher · View at Google Scholar
  • Soha Ahmadi, Iraklii I. Ebralidze, Heinz-Bernhard Kraatz, and Zhe She, “Electrochemical studies of tau protein-iron interactions—Potential implications for Alzheimer's Disease,” Electrochimica Acta, vol. 236, pp. 384–393, 2017. View at Publisher · View at Google Scholar
  • Seema Patel, “Disruption of aromatase homeostasis as the cause of a multiplicity of ailments: A comprehensive review,” The Journal of Steroid Biochemistry and Molecular Biology, vol. 168, pp. 19–25, 2017. View at Publisher · View at Google Scholar
  • Rafael Martín-Rapún, Laura de Matteis, Jesús M. de la Fuente, Alfredo Ambrosone, Sonia García-Embid, and Lucía Gutiérrez, “Targeted nanoparticles for the treatment of Alzheimer’s disease,” Current Pharmaceutical Design, vol. 23, no. 13, pp. 1927–1952, 2017. View at Publisher · View at Google Scholar
  • Gabriel Pascual, Jehangir S. Wadia, Xueyong Zhu, Elissa Keogh, Başak Kükrer, Jeroen van Ameijde, Hanna Inganäs, Berdien Siregar, Gerrard Perdok, Otto Diefenbach, Tariq Nahar, Imke Sprengers, Martin H. Koldijk, Els C. Brinkman-van der Linden, Laura A. Peferoen, Heng Zhang, Wenli Yu, Xinyi Li, Michelle Wagner, Veronica Moreno, Julie Kim, Martha Costa, Kiana West, Zara Fulton, Lucy Chammas, Nancy Luckashenak, Lauren Fletcher, Trevin Holland, Carrie Arnold, R. Anthony Williamson, Jeroen J. Hoozemans, Adrian Apetri, Frederique Bard, Ian A. Wilson, Wouter Koudstaal, and Jaap Goudsmit, “Immunological memory to hyperphosphorylated tau in asymptomatic individuals,” Acta Neuropathologica, 2017. View at Publisher · View at Google Scholar
  • Usman Saeed, Walter Swardfager, Sandra E. Black, and Mario Masellis, “Biomarkers of Alzheimer’s Disease,” Mental Health and Illness of the Elderly, pp. 1–35, 2017. View at Publisher · View at Google Scholar
  • Zongxiao He, Alan E. Renton, Biao Li, Linhai Zhao, Gao T. Wang, Suzanne M. Leal, Di Zhang, Alison M. Goate, and Richard Mayeux, “The Rare-Variant Generalized Disequilibrium Test for Association Analysis of Nuclear and Extended Pedigrees with Application to Alzheimer Disease WGS Data,” American Journal of Human Genetics, vol. 100, no. 2, pp. 193–204, 2017. View at Publisher · View at Google Scholar
  • Dmitriy V Prokopovich, John W Whittaker, Micaiah M Muthee, Azka Ahmed, and Luca Larini, “Impact of Phosphorylation and Pseudo-Phosphorylation on the Early Stages of Aggregation of the Microtubule Associated Protein Tau,” The Journal of Physical Chemistry B, 2017. View at Publisher · View at Google Scholar
  • Sidney S. Dicke, Paige E. Engen, Larry R. Masterson, Lexus Tatge, and Megan Culp, “Isothermal titration calorimetry and vesicle leakage assays highlight the differential behaviors of tau repeat segments upon interaction with anionic lipid membranes,” Biochemical and Biophysical Research Communications, vol. 493, no. 4, pp. 1504–1509, 2017. View at Publisher · View at Google Scholar
  • Tamás Vajda, and András Perczel, “The impact of water on the ambivalent behavior and paradoxical phenomenon of the amyloid-β fibril protein,” Biomolecular Concepts, vol. 8, no. 5-6, pp. 213–220, 2017. View at Publisher · View at Google Scholar
  • Bjørn Holst, Julianna Kobolák, András Dinnyés, Balázs Mihalik, István Bock, Anna Ochalek, Lajos László, Jørgen E. Nielsen, Kristine Freude, Poul Hyttel, Hasan X. Avci, Abinaya Chandrasekaran, Annamária Téglási, Maria Lo Giudice, Zsuzsanna Táncos, and Kinga Molnár, “Neurons derived from sporadic Alzheimer's disease iPSCs reveal elevated TAU hyperphosphorylation, increased amyloid levels, and GSK3B activation,” Alzheimer's Research and Therapy, vol. 9, no. 1, 2017. View at Publisher · View at Google Scholar
  • Laura Llorach-Pares, Alfons Nonell-Canals, Melchor Sanchez-Martinez, and Conxita Avila, “Computer-Aided Drug Design Applied to Marine Drug Discovery: Meridianins as Alzheimer’s Disease Therapeutic Agents,” Marine Drugs, vol. 15, no. 12, pp. 366, 2017. View at Publisher · View at Google Scholar
  • Zhong-Yue Lv, Chen-Chen Tan, Jin-Tai Yu, and Lan Tan, “Spreading of Pathology in Alzheimer’s Disease,” Neurotoxicity Research, vol. 32, no. 4, pp. 707–722, 2017. View at Publisher · View at Google Scholar
  • Usman Saeed, Walter Swardfager, Sandra E. Black, and Mario Masellis, “Biomarkers of Alzheimer’s Disease,” Mental Health and Illness of the Elderly, pp. 105–139, 2017. View at Publisher · View at Google Scholar
  • Seema Patel, Abdur Rauf, Haroon Khan, and Tareq Abu-Izneid, “Renin-angiotensin-aldosterone (RAAS): The ubiquitous system for homeostasis and pathologies,” Biomedicine & Pharmacotherapy, vol. 94, pp. 317–325, 2017. View at Publisher · View at Google Scholar
  • Marie Jouanne, Sylvain Rault, and Anne-Sophie Voisin-Chiret, “Tau protein aggregation in Alzheimer's disease: An attractive target for the development of novel therapeutic agents,” European Journal of Medicinal Chemistry, vol. 139, pp. 153–167, 2017. View at Publisher · View at Google Scholar
  • Erdenedolgor Erdene-Ochir, Cheol-Ho Pan, and Md Nazmul Huda, “Assay for phosphorylation and microtubule binding along with localization of tau protein in colorectal cancer cells,” Journal of Visualized Experiments, vol. 2017, no. 128, 2017. View at Publisher · View at Google Scholar
  • Jinsoo Seo, Jay Penney, Catarina Silva, Steven D. Sheridan, Diane Lucente, Bradford C. Dickerson, Stephen J. Haggarty, Li-Huei Tsai, Ashley Watson, Scarlett J. Barker, Dilip Dey, Tak Ko, Sukhee Cho, James F. Gusella, Oleg Kritskiy, Waseem K. Raja, and Yuan-Ta Lin, “Inhibition of p25/Cdk5 attenuates tauopathy in mouse and iPSC models of frontotemporal dementia,” Journal of Neuroscience, vol. 37, no. 41, pp. 9917–9924, 2017. View at Publisher · View at Google Scholar
  • Vicente Gallego, M. Luz Calle, and Ramon Oller, “Kernel-Based Measure of Variable Importance for Genetic Association Studies,” The International Journal of Biostatistics, no. 0, 2017. View at Publisher · View at Google Scholar
  • Michala Kolarova, Urmi Sengupta, Ales Bartos, Jan Ricny, and Rakez Kayed, “Tau Oligomers in Sera of Patients with Alzheimer's Disease and Aged Controls,” Journal of Alzheimer's Disease, vol. 58, no. 2, pp. 471–478, 2017. View at Publisher · View at Google Scholar
  • Yang Yang, Xingxing Jia, Jianchao Feng, Zhiyong Wang, Yu Cao, Jiangang Liu, and Hao Li, “Fuzheng Quxie Decoction Ameliorates Learning and Memory Impairment in SAMP8 Mice by Decreasing Tau Hyperphosphorylation,” Evidence-Based Complementary and Alternative Medicine, vol. 2017, pp. 1–11, 2017. View at Publisher · View at Google Scholar
  • Dongdong Su, Yun Kyung Kim, Sungsu Lim, Md. Mamunul Haque, Dohee Kim, Jun-Seok Lee, and Young-Tae Chang, “Development of a BODIPY-based fluorescent probe for imaging pathological tau aggregates in live cells,” Chemical Communications, vol. 53, no. 10, pp. 1607–1610, 2017. View at Publisher · View at Google Scholar
  • Shaohui Wang, Pengyan Zhang, Ruifang Liu, Yuan Li, Chao Liu, and Xiaomei Liao, “A DEHP plasticizer alters synaptic proteins via peroxidation,” Toxicology Research, vol. 6, no. 1, pp. 89–97, 2017. View at Publisher · View at Google Scholar
  • S. Mondragón-Rodríguez, G. Perry, and F. Peña-Ortega, “Tau Proteins,” Drug Discovery Approaches for the Treatment of Neurodegenerative Disorders, pp. 145–160, 2017. View at Publisher · View at Google Scholar
  • T. V. Gorbach, O. A. Nakonechna, A. S. Tkachenko, T. S. Shcholok, and A. O. Onikova, “Levels of Thyroid Hormones and Indices of Energy Metabolism in the Cerebral Cortex of Rats with Experimental Alzheimer’s Disease,” Neurophysiology, 2018. View at Publisher · View at Google Scholar
  • Seema Patel, “Danger-Associated Molecular Patterns (DAMPs): the Derivatives and Triggers of Inflammation,” Current Allergy and Asthma Reports, vol. 18, no. 11, 2018. View at Publisher · View at Google Scholar
  • Hyun Jin Cho, and Inhee Mook-Jung, “O-GlcNAcylation regulates endoplasmic reticulum exit sites through Sec31A modification in conventional secretory pathway,” FASEB Journal, vol. 32, no. 9, pp. 4641–4657, 2018. View at Publisher · View at Google Scholar
  • Minee L. Choi, and Sonia Gandhi, “Crucial role of protein oligomerization in the pathogenesis of Alzheimer's and Parkinson's diseases,” The FEBS Journal, 2018. View at Publisher · View at Google Scholar
  • Katherine Zukotynski, Phillip H. Kuo, Pedro Rosa-Neto, Sandra E. Black, David Mikulis, Antonio P. Strafella, and Rathan M. Subramaniam, “PET/CT of dementia,” American Journal of Roentgenology, vol. 211, no. 2, pp. 246–259, 2018. View at Publisher · View at Google Scholar
  • Stylianos Ravanidis, Fedon-Giasin Kattan, and Epaminondas Doxakis, “Unraveling the Pathways to Neuronal Homeostasis and Disease: Mechanistic Insights into the Role of RNA-Binding Proteins and Associated Factors,” International Journal of Molecular Sciences, vol. 19, no. 8, pp. 2280, 2018. View at Publisher · View at Google Scholar
  • María J. Pérez, Claudia Jara, and Rodrigo A. Quintanilla, “Contribution of Tau Pathology to Mitochondrial Impairment in Neurodegeneration,” Frontiers in Neuroscience, vol. 12, 2018. View at Publisher · View at Google Scholar
  • Jeroen van Ameijde, Rosa Crespo, Roosmarijn Janson, Jarek Juraszek, Berdien Siregar, Hanneke Verveen, Imke Sprengers, Tariq Nahar, Jeroen J. Hoozemans, Stefan Steinbacher, Roland Willems, Lore Delbroek, Marianne Borgers, Koen Dockx, Kristof Van Kolen, Marc Mercken, Gabriel Pascual, Wouter Koudstaal, and Adrian Apetri, “Enhancement of therapeutic potential of a naturally occurring human antibody targeting a phosphorylated Ser422 containing epitope on pathological tau,” Acta Neuropathologica Communications, vol. 6, no. 1, 2018. View at Publisher · View at Google Scholar
  • Hui-Yun Chang, Tzu-Kang Sang, and Ann-Shyn Chiang, “Untangling the Tauopathy for Alzheimer’s disease and parkinsonism,” Journal of Biomedical Science, vol. 25, no. 1, 2018. View at Publisher · View at Google Scholar
  • Esraa Haj, Yelena Losev, Edward Pichinuk, Hamutal Engel, Avi Raveh, Daniel Segal, Guru KrishnaKumar, and Ehud Gazit, “Integrating in vitro and in silico approaches to evaluate the “dual functionality” of palmatine chloride in inhibiting and disassembling Tau-derived VQIVYK peptide fibrils,” Biochimica et Biophysica Acta - General Subjects, vol. 1862, no. 7, pp. 1565–1575, 2018. View at Publisher · View at Google Scholar
  • Daphney C. Jean, Mei Liu, Liang Qiang, Xiaohuan Sun, Timothy O. Austin, Hemalatha Muralidharan, Wenqian Yu, and Peter W. Baas, “Tau Does Not Stabilize Axonal Microtubules but Rather Enables Them to Have Long Labile Domains,” Current Biology, vol. 28, no. 13, pp. 2181–2189.e4, 2018. View at Publisher · View at Google Scholar
  • Seema Patel, Ahmad Homaei, Akondi Butchi Raju, and Biswa Ranjan Meher, “Estrogen: The necessary evil for human health, and ways to tame it,” Biomedicine & Pharmacotherapy, vol. 102, pp. 403–411, 2018. View at Publisher · View at Google Scholar
  • S. Vela, Neira Sainz, María J. Moreno-Aliaga, M. Solas, and María J. Ramirez, “DHA Selectively Protects SAMP-8-Associated Cognitive Deficits Through Inhibition of JNK,” Molecular Neurobiology, 2018. View at Publisher · View at Google Scholar
  • Philip Ryan, Bhautikkumar Patel, Vivek Makwana, Hemant R. Jadhav, Milton Kiefel, Andrew Davey, Tristan A. Reekie, Santosh Rudrawar, and Michael Kassiou, “Peptides, Peptidomimetics, and Carbohydrate–Peptide Conjugates as Amyloidogenic Aggregation Inhibitors for Alzheimer’s Disease,” ACS Chemical Neuroscience, 2018. View at Publisher · View at Google Scholar
  • Aristo Vojdani, and Elroy Vojdani, “Amyloid-Beta 1-42 Cross-Reactive Antibody Prevalent in Human Sera May Contribute to Intraneuronal Deposition of A-Beta-P-42,” International Journal of Alzheimer's Disease, vol. 2018, pp. 1–12, 2018. View at Publisher · View at Google Scholar
  • Cuicui Yang, Xuelian Li, Wenbin Gao, Qi Wang, Li Zhang, Yali Li, Lin Li, and Lan Zhang, “Cornel Iridoid Glycoside Inhibits Tau Hyperphosphorylation via Regulating Cross-Talk Between GSK-3β and PP2A Signaling,” Frontiers in Pharmacology, vol. 9, 2018. View at Publisher · View at Google Scholar
  • Maja Jazvinšćak Jembrek, Neda Slade, Patrick R. Hof, and Goran Šimić, “The interactions of p53 with tau and Aß represent potential therapeutic targets for Alzheimer’s disease,” Progress in Neurobiology, 2018. View at Publisher · View at Google Scholar
  • Mohammad Reza Ashrafi-Kooshk, Seyed Shahriar Arab, Ali Akbar Moosavi-Movahedi, Reza Khodarahmi, Abolfazl Jangholi, Saeed Karima, Mansour Poorebrahim, and Seyyed Abolghasem Ghadami, “Can any “non-specific charge modification within microtubule binding domains of Tau” be a prerequisite of the protein amyloid aggregation? An in vitro study on the 1N4R isoform,” International Journal of Biological Macromolecules, vol. 109, pp. 188–204, 2018. View at Publisher · View at Google Scholar
  • Simon Koblar, Shohreh Majd, and John Power, “Compound C enhances tau phosphorylation at Serine396 via PI3K activation in an AMPK and rapamycin independent way in differentiated SH-SY5Y cells,” Neuroscience Letters, vol. 670, pp. 53–61, 2018. View at Publisher · View at Google Scholar
  • Daniel Muñoz-Mayorga, Christian Guerra-Araiza, Luz Torner, and Teresa Morales, “Tau Phosphorylation in Female Neurodegeneration: Role of Estrogens, Progesterone, and Prolactin,” Frontiers in Endocrinology, vol. 9, 2018. View at Publisher · View at Google Scholar
  • Steven A. Harris, and Elizabeth A. Harris, “Molecular Mechanisms for Herpes Simplex Virus Type 1 Pathogenesis in Alzheimer’s Disease,” Frontiers in Aging Neuroscience, vol. 10, 2018. View at Publisher · View at Google Scholar
  • Yoori Choi, Seunggyun Ha, Dong Jin Kim, Yun Kyung Kim, Yun-Sang Lee, and Dong Soo Lee, “Development of tau PET Imaging Ligands and their Utility in Preclinical and Clinical Studies,” Nuclear Medicine and Molecular Imaging, vol. 52, no. 1, pp. 24–30, 2018. View at Publisher · View at Google Scholar
  • Cheril Tapia-Rojas, Fabian Cabezas-Opazo, Carol A. Deaton, Erick H. Vergara, Gail V.W. Johnson, and Rodrigo A. Quintanilla, “It’s all about tau,” Progress in Neurobiology, 2018. View at Publisher · View at Google Scholar
  • Heng Zhang, Jaap Goudsmit, Adrian Apetri, Wouter Koudstaal, Xueyong Zhu, Hanna Inganäs, Ian A. Wilson, Gabriel Pascual, Jehangir S. Wadia, Elissa Keogh, Jeroen J. Hoozemans, Berdien Siregar, and Esther J.M. Stoop, “Structural Basis for Recognition of a Unique Epitope by a Human Anti-tau Antibody,” Structure, vol. 26, no. 12, pp. 1626–1634.e4, 2018. View at Publisher · View at Google Scholar
  • Hasan A.M.M. Almansoub, Hui Tang, Ying Wu, Ding-Qi Wang, Yacoubou Abdoul Razak Mahaman, Na Wei, Yusra A. M. Almansob, Wei He, and Dan Liu, “Tau Abnormalities and the Potential Therapy in Alzheimer’s Disease,” Journal of Alzheimer's Disease, pp. 1–21, 2018. View at Publisher · View at Google Scholar
  • Yeong Jung, Yoon Kim, Mridula Bhalla, Sung Lee, and Jinsoo Seo, “Genomics: New Light on Alzheimer’s Disease Research,” International Journal of Molecular Sciences, vol. 19, no. 12, pp. 3771, 2018. View at Publisher · View at Google Scholar
  • Young-Kook Kim, and Juhyun Song, “The Role of Long Noncoding RNAs in Diabetic Alzheimer’s Disease,” Journal of Clinical Medicine, vol. 7, no. 11, pp. 461, 2018. View at Publisher · View at Google Scholar
  • Laura Llorach-Pares, Alfons Nonell-Canals, Conxita Avila, and Melchor Sanchez-Martinez, “Kororamides, Convolutamines, and Indole Derivatives as Possible Tau and Dual-Specificity Kinase Inhibitors for Alzheimer’s Disease: A Computational Study,” Marine Drugs, vol. 16, no. 10, pp. 386, 2018. View at Publisher · View at Google Scholar
  • Graf, Lehmann, Ludolph, and Wurster, “Antisense oligonucleotides II: Treatment options in neuropsychiatric disorders, ethical and healthcare implications,” Nervenheilkunde, vol. 37, no. 11, pp. 818–825, 2018. View at Publisher · View at Google Scholar
  • Virginie Stoppin-Mellet, Christophe Bosc, Anne Fourest-Lieuvin, Annie Andrieux, Elea Prezel, Elie Auréliane, Isabelle Arnal, Marylin Vantard, Julie Delaroche, and Laurence Serre, “Tau can switch microtubule network organizations: from random networks to dynamic and stable bundles,” Molecular Biology of the Cell, vol. 29, no. 2, pp. 154–165, 2018. View at Publisher · View at Google Scholar
  • Claudia D. Wurster, and Albert C. Ludolph, “Antisense oligonucleotides in neurological disorders,” Therapeutic Advances in Neurological Disorders, vol. 11, 2018. View at Publisher · View at Google Scholar
  • Anne Kim, Sungsu Lim, and Yun Kim, “Metal Ion Effects on Aβ and Tau Aggregation,” International Journal of Molecular Sciences, vol. 19, no. 2, pp. 128, 2018. View at Publisher · View at Google Scholar
  • V. Guru KrishnaKumar, Ashim Paul, Ehud Gazit, and Daniel Segal, “Mechanistic insights into remodeled Tau-derived PHF6 peptide fibrils by Naphthoquinone-Tryptophan hybrids,” Scientific Reports, vol. 8, no. 1, 2018. View at Publisher · View at Google Scholar
  • Peng Wang, Xuefei Huang, Filippa Lo Cascio, Jia Gao, and Rakez Kayed, “Binding and neurotoxicity mitigation of toxic tau oligomers by synthetic heparin like oligosaccharides,” Chemical Communications, vol. 54, no. 72, pp. 10120–10123, 2018. View at Publisher · View at Google Scholar
  • Sławomir Wójcik, Melissa Birol, Elizabeth Rhoades, Andrew D. Miranker, and Zachary A. Levine, “Targeting the Intrinsically Disordered Proteome Using Small-Molecule Ligands,” 2018. View at Publisher · View at Google Scholar
  • Mehrdad Jahanshahi, Mohsen Saeidi, and Gozal Bahlakeh, “Human chorionic gonadotropin decreases the phosphorylated tau protein level in streptozotocin-Alzheimeric male rats' hippocampus,” Folia Neuropathologica, vol. 56, no. 2, pp. 141–150, 2018. View at Publisher · View at Google Scholar
  • Fanny Rodríguez-Cruz, Francisco Miguel Torres-Cruz, Hugo Christian Monroy-Ramírez, Jaime Escobar-Herrera, Jesús Avila, Francisco García-Sierra, and Gustavo Basurto-Islas, “Fragmentation of the Golgi Apparatus in Neuroblastoma Cells Is Associated with Tau-Induced Ring-Shaped Microtubule Bundles,” Journal of Alzheimer's Disease, vol. 65, no. 4, pp. 1185–1207, 2018. View at Publisher · View at Google Scholar
  • Kin Yen Chia, Khuen Yen Ng, Rhun Yian Koh, and Soi Moi Chye, “Single-chain Fv antibodies for targeting neurodegenerative diseases,” CNS and Neurological Disorders - Drug Targets, vol. 17, no. 9, pp. 671–679, 2018. View at Publisher · View at Google Scholar
  • Vishwambhar Vishnu Bhandare, Bajarang Vasant Kumbhar, and Ambarish Kunwar, “Differential binding affinity of tau repeat region R2 with neuronal-specific β-tubulin isotypes,” Scientific Reports, vol. 9, no. 1, 2019. View at Publisher · View at Google Scholar
  • Odete A.B. da Cruz e Silva, Diogo Trigo, and André Nadais, “Unravelling protein aggregation as an ageing related process or a neuropathological response,” Ageing Research Reviews, vol. 51, pp. 67–77, 2019. View at Publisher · View at Google Scholar
  • Md. Mamunul Haque, Dhiraj P. Murale, Yun Kyung Kim, and Jun-Seok Lee, “Crosstalk between Oxidative Stress and Tauopathy,” International Journal of Molecular Sciences, vol. 20, no. 8, pp. 1959, 2019. View at Publisher · View at Google Scholar
  • Eftychia Vasili, Antonio Dominguez-Meijide, and Tiago Fleming Outeiro, “Spreading of α-Synuclein and Tau: A Systematic Comparison of the Mechanisms Involved,” Frontiers in Molecular Neuroscience, vol. 12, 2019. View at Publisher · View at Google Scholar
  • Rohit Pardeshi, Nityanand Bolshette, Kundlik Gadhave, Mohammad Arfeen, Sahabuddin Ahmed, Rohitash Jamwal, Bruce D. Hammock, Mangala Lahkar, and Sumanta Kumar Goswami, “Docosahexaenoic Acid Increases the Potency of Soluble Epoxide Hydrolase Inhibitor in Alleviating Streptozotocin-Induced Alzheimer’s Disease-Like Complications of Diabetes,” Frontiers in Pharmacology, vol. 10, 2019. View at Publisher · View at Google Scholar
  • Tarsila Castro, Florentina-Daniela Munteanu, and Artur Cavaco-Paulo, “Electrostatics of Tau Protein by Molecular Dynamics,” Biomolecules, vol. 9, no. 3, pp. 116, 2019. View at Publisher · View at Google Scholar
  • Astrid Sydow, Stefanie Vogel, Dirk Wiedermann, Eckhard Mandelkow, Mathias Hoehn, Claudia Green, Marta Anglada-Huguet, and Eva-Maria Mandelkow, “Functional networks are impaired by elevated tau-protein but reversible in a regulatable Alzheimer's disease mouse model,” Molecular Neurodegeneration, vol. 14, no. 1, 2019. View at Publisher · View at Google Scholar
  • Luisa F. Duarte, Mónica A. Farías, Diana M. Álvarez, Susan M. Bueno, Claudia A. Riedel, and Pablo A. González, “Herpes Simplex Virus Type 1 Infection of the Central Nervous System: Insights Into Proposed Interrelationships With Neurodegenerative Disorders,” Frontiers in Cellular Neuroscience, vol. 13, 2019. View at Publisher · View at Google Scholar
  • Shahrzad Talebian, Jalal Gharesouran, Soudeh Ghafouri-Fard, Behnaz Salek Esfahani, Shahram Arsang-Jang, Mir Davood Omrani, Mohammad Taheri, and Maryam Rezazadeh, “Assessment of expression of RELN signaling pathway in multiple sclerosis patients,” Immunobiology, 2019. View at Publisher · View at Google Scholar
  • Hao Chi, Tzu-Kang Sang, and Hui-Yun Chang, “Tauopathy,” Cognitive Disorders, 2019. View at Publisher · View at Google Scholar
  • BhaskarC Das, Somsankar Dasgupta, and SwapanK Ray, “Potential therapeutic roles of retinoids for prevention of neuroinflammation and neurodegeneration in Alzheimer’s disease,” Neural Regeneration Research, vol. 14, no. 11, pp. 1880, 2019. View at Publisher · View at Google Scholar